BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21539296)

  • 41. Metastable, partially folded states in the productive folding and in the misfolding and amyloid aggregation of proteins.
    Ferreira ST; De Felice FG; Chapeaurouge A
    Cell Biochem Biophys; 2006; 44(3):539-48. PubMed ID: 16679542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation.
    van Ham TJ; Esposito A; Kumita JR; Hsu ST; Kaminski Schierle GS; Kaminski CF; Dobson CM; Nollen EA; Bertoncini CW
    J Mol Biol; 2010 Jan; 395(3):627-42. PubMed ID: 19891973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High hydrostatic pressure dissociates early aggregates of TTR105-115, but not the mature amyloid fibrils.
    Dirix C; Meersman F; MacPhee CE; Dobson CM; Heremans K
    J Mol Biol; 2005 Apr; 347(5):903-9. PubMed ID: 15784251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amyloid aggregation on lipid bilayers and its impact on membrane permeability.
    Friedman R; Pellarin R; Caflisch A
    J Mol Biol; 2009 Mar; 387(2):407-15. PubMed ID: 19133272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Misfolding of amyloidogenic proteins at membrane surfaces: the impact of macromolecular crowding.
    Bokvist M; Gröbner G
    J Am Chem Soc; 2007 Dec; 129(48):14848-9. PubMed ID: 17990885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel insights into protein misfolding diseases revealed by ion mobility-mass spectrometry.
    Williams DM; Pukala TL
    Mass Spectrom Rev; 2013; 32(3):169-87. PubMed ID: 23345084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small molecule fluorescent probes for the detection of amyloid self-assembly in vitro and in vivo.
    Bertoncini CW; Celej MS
    Curr Protein Pept Sci; 2011 May; 12(3):205-20. PubMed ID: 21348839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interactions between a luminescent conjugated oligoelectrolyte and insulin during early phases of amyloid formation.
    Wigenius J; Persson G; Widengren J; Inganäs O
    Macromol Biosci; 2011 Aug; 11(8):1120-7. PubMed ID: 21557477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Learnings from Protein Folding Projected onto Amyloid Misfolding.
    Sreenivasan S; Narayan M
    ACS Chem Neurosci; 2019 Sep; 10(9):3911-3913. PubMed ID: 31456389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein folding, misfolding, aggregation and their implications in human diseases: discovering therapeutic ways to amyloid-associated diseases.
    Iram A; Naeem A
    Cell Biochem Biophys; 2014 Sep; 70(1):51-61. PubMed ID: 24639112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conformational diseases: looking into the eyes.
    Surguchev A; Surguchov A
    Brain Res Bull; 2010 Jan; 81(1):12-24. PubMed ID: 19808079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metal complexes for multimodal imaging of misfolded protein-related diseases.
    Lacerda S; Morfin JF; Geraldes CFGC; Tóth É
    Dalton Trans; 2017 Oct; 46(42):14461-14474. PubMed ID: 28952628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Examining ubiquitinated protein aggregates in tissue sections.
    Kaniuk NA; Brumell JH
    Methods Mol Biol; 2010; 648():175-82. PubMed ID: 20700712
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extracellular chaperones and proteostasis.
    Wyatt AR; Yerbury JJ; Ecroyd H; Wilson MR
    Annu Rev Biochem; 2013; 82():295-322. PubMed ID: 23350744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein misfolding and obstructive lung disease.
    Greene CM; McElvaney NG
    Proc Am Thorac Soc; 2010 Nov; 7(6):346-55. PubMed ID: 21030512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quality control system response to stochastic growth of amyloid fibrils.
    Pigolotti S; Lizana L; Otzen D; Sneppen K
    FEBS Lett; 2013 May; 587(9):1405-10. PubMed ID: 23524241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimization of an amplification protocol for misfolded proteins by using relaxed control.
    Coron JM; Gabriel P; Shang P
    J Math Biol; 2015 Jan; 70(1-2):289-327. PubMed ID: 24567169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbial manipulation of the amyloid fold.
    DePas WH; Chapman MR
    Res Microbiol; 2012; 163(9-10):592-606. PubMed ID: 23108148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein misfolding and human disease.
    Gregersen N; Bross P; Vang S; Christensen JH
    Annu Rev Genomics Hum Genet; 2006; 7():103-24. PubMed ID: 16722804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imaging and quantification of amyloid fibrillation in the cell nucleus.
    Arnhold F; Scharf A; von Mikecz A
    Methods Mol Biol; 2015; 1228():187-202. PubMed ID: 25311131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.